Loading…

Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease

Abstract Rationale Health-related quality of life (HRQL) is impaired among patients with interstitial lung disease (ILD). Little is understood about HRQL in specific subtypes of ILD. Objectives The aim of this study was to characterize and identify clinical determinants of HRQL among patients with r...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine 2017-06, Vol.127, p.1-6
Main Authors: Natalini, Jake G., M.D, Swigris, Jeff J., D.O., M.S, Morisset, Julie, M.D, Elicker, Brett M., M.D, Jones, Kirk D., M.D, Fischer, Aryeh, M.D, Collard, Harold R., M.D, Lee, Joyce S., M.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Rationale Health-related quality of life (HRQL) is impaired among patients with interstitial lung disease (ILD). Little is understood about HRQL in specific subtypes of ILD. Objectives The aim of this study was to characterize and identify clinical determinants of HRQL among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and compare them to patients with idiopathic pulmonary fibrosis (IPF). Methods We identified patients with a diagnosis of RA-ILD and IPF from an ongoing longitudinal cohort of ILD patients. HRQL was measured at their baseline visit using the Short Form Health Survey (SF-36), versions 1 and 2. Regression models were used to characterize and understand the relationship between selected baseline clinical covariates, the physical component score (PCS) and mental component score (MCS) of the SF-36. Measurements and main results RA-ILD patients (n = 50) were more likely to be younger and female compared to IPF patients (n = 50). After controlling for age and pulmonary function, RA-ILD patients had a lower HRQL compared to IPF patients, as measured by the PCS ( P  = 0.03), with significant differences in two of four PCS domains – bodily pain ( P  
ISSN:0954-6111
1532-3064
DOI:10.1016/j.rmed.2017.04.002